IVVD - Latest News
Invivyd, Inc. (IVVD), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $262.7M. Beta to the broader market is 0.63.
The article list below shows the most recent IVVD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent IVVD Headlines
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
globenewswire.com - Jun 29, 2026
ROCKVILLE, Md. , June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceu
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
globenewswire.com - Jun 16, 2026
NEW HAVEN, Conn. , June 16, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc.
Invivyd doses first participants in Phase 3 COVID-19 trial
proactiveinvestors.com - Jun 9, 2026
Invivyd Inc (NASDAQ:IVVD) has dosed the first participants in its LIBERTY Phase 3 trial, a study testing the company's monoclonal antibody VYD2311 for
Invivyd doses first participants in Phase 3 COVID-19 trial
proactiveinvestors.com - Jun 9, 2026
Invivyd Inc (NASDAQ:IVVD) has dosed the first participants in its LIBERTY Phase 3 trial, a study testing the company's monoclonal antibody VYD2311 for
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration
globenewswire.com - Jun 9, 2026
NEW HAVEN, Conn. , June 09, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc.
How News Affects IVVD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IVVD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked IVVD news questions
- What is the latest IVVD news headline?
- The most recent IVVD headline (Jun 29, 2026) is "NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the IVVD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What IVVD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual IVVD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.